Sanofi-aventis will comply with the European Authorities request to temporarily suspend the marketing authorisation of Acomplia® in obese and overweight patients and will make every effort to actively support patients and Health Care Professionals.
Champions Hope to Inspire People Living with Uncontrolled Blood Sugar Levels to Join the Circle and Pledge to Get Serious About Managing Their Diabetes
Randomized, double-blind, placebo-controlled study conducted in the U.S. demonstrated both the efficacy and safety of Nasacort AQ® in children with nasal symptoms associated with perennial allergic rhinitis